
Personalis PSNL
$ 6.07
9.17%
Quarterly report 2025-Q3
added 11-04-2025
Personalis EV - Enterprise Value 2011-2026 | PSNL
Annual EV - Enterprise Value Personalis
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 229 M | 143 M | 128 M | 441 M | 1.04 B | 203 M | 148 M | 126 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.04 B | 126 M | 308 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Myriad Genetics
MYGN
|
598 M | $ 4.11 | -18.29 % | $ 381 M | ||
|
National Research Corporation
NRC
|
432 M | $ 17.86 | -4.7 % | $ 400 M | ||
|
Koninklijke Philips N.V.
PHG
|
43.5 B | $ 27.23 | 2.95 % | $ 20 B | ||
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 17.01 | -0.09 % | $ 179 M | ||
|
Agilent Technologies
A
|
45.8 B | $ 117.69 | 0.14 % | $ 35.8 B | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 20.94 | 1.16 % | $ 1.12 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 1.64 | 3.14 % | $ 2.18 M | ||
|
Castle Biosciences
CSTL
|
463 M | $ 24.75 | 0.61 % | $ 687 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Medpace Holdings
MEDP
|
14 B | - | - | $ 12.3 B | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 181.73 | -1.97 % | $ 9.01 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
1.85 B | $ 8.89 | 0.34 % | $ 1.14 B | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Natera
NTRA
|
5.53 B | $ 215.09 | 4.02 % | $ 21.2 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 14.92 | 0.13 % | $ 451 M | ||
|
Guardant Health
GH
|
15.2 B | $ 92.25 | 3.05 % | $ 11.6 B | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
Soleno Therapeutics
SLNO
|
2.13 B | $ 52.94 | 0.04 % | $ 2.69 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 124.13 | 2.32 % | $ 10.2 B | ||
|
Illumina
ILMN
|
15.3 B | $ 142.58 | 2.52 % | $ 22.7 B | ||
|
Senseonics Holdings
SENS
|
376 M | $ 5.36 | 7.2 % | $ 224 M | ||
|
Interpace Biosciences
IDXG
|
16.3 M | - | - | $ 9.33 M | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Thermo Fisher Scientific
TMO
|
186 B | $ 472.95 | 1.33 % | $ 178 B | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.21 | 1.14 % | $ 5.08 M | ||
|
Trinity Biotech plc
TRIB
|
327 M | $ 0.6 | 0.42 % | $ 61.9 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 86.15 | 0.38 % | $ 5.81 B | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 256.94 | -0.08 % | $ 21.4 B | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 59.53 | 4.99 % | $ 3.56 B | ||
|
Celcuity
CELC
|
5.57 B | - | - | $ 6.52 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.18 | -0.97 % | $ 1.99 B | ||
|
Waters Corporation
WAT
|
21.6 B | $ 349.53 | 1.98 % | $ 20.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 189.13 | -0.9 % | $ 21 B |